Assessing disease onset and progression in the SOD1 mouse model of ALS

This publication has 11 references indexed in Scilit:

• Pathways to motor neuron degeneration in transgenic mouse models
  Biochimie, 2002
• Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS
  Annals of Neurology, 2002
• Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation
  Neuropathology, 2001
• Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
  Nature Medicine, 1999
• Massive Mitochondrial Degeneration in Motor Neurons Triggers the Onset of Amyotrophic Lateral Sclerosis in Mice Expressing a Mutant SOD1
  Journal of Neuroscience, 1998
• Quantitative motor assessment in FALS mice
  NeuroReport, 1997
• A low expressor line of transgenic mice carrying a mutant human Cu,Zn superoxide dismutase ( SOD1 ) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis
  Acta Neuropathologica, 1997
• Mice lacking both subunits of lysosomal β–hexosaminidase display gangliosidosis and mucopolysaccharidosis
  Nature Genetics, 1996
• Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosis
  Annals of Neurology, 1996
• Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
  Science, 1994